Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

33.60
-0.1800-0.53%
Post-market: 34.160.5600+1.67%19:30 EDT
Volume:2.03M
Turnover:68.25M
Market Cap:2.41B
PE:-5.70
High:34.29
Open:33.49
Low:32.88
Close:33.78
52wk High:56.05
52wk Low:22.72
Shares:71.71M
Float Shares:52.39M
Volume Ratio:1.62
T/O Rate:3.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.91
PE(LYR):-7.20

Loading ...

Vera Therapeutics (VERA) Receives a Buy from Evercore ISI

TIPRANKS
·
May 15

Vera Therapeutics CEO Marshall Fordyce disposes 18,500 shares for $834,058

Reuters
·
May 14

Vera Therapeutics grants inducement equity awards to 10 new hires, sets options at $35.51

Reuters
·
May 09

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 09

Vera Therapeutics: Buy Rating Reiterated on Strong Atacicept Outlook and Launch Readiness; $73 Price Target Maintained

TIPRANKS
·
May 08

Kodiak Begins Hauling Freight Autonomously With Roehl Transport

GlobeNewswire
·
May 08

Vera Therapeutics reports Q1 EPS ($1.69), consensus ($1.37)

TIPRANKS
·
May 08

Vera Therapeutics (VERA) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 08

Vera Therapeutics, Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Vera Therapeutics Q1 EPS $(1.69) Misses $(1.34) Estimate

Benzinga Earnings
·
May 07

Vera Therapeutics Q1 net loss widens to $121.03 million

Reuters
·
May 07

BRIEF-Vera Therapeutics Q1 EPS USD -1.69 Vs. IBES Estimate USD -1.33

Reuters
·
May 07

Vera Therapeutics, Inc - U.S. Commercial Launch of Atacicept Expected Mid-2026, Pending Approval

THOMSON REUTERS
·
May 07

Vera Therapeutics, Inc - $596.8 Mln in Cash, Cash Equivalents, and Marketable Securities as of March 31, 2026

THOMSON REUTERS
·
May 07

Press Release: Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Vera Therapeutics to present at Bank of America Securities 2026 Health Care Conference

Reuters
·
May 04

Vera CEO Marshall Fordyce disposes of Vera Therapeutics shares worth $1,018,054

Reuters
·
Apr 16

BRIEF-Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 11

Vera Therapeutics grants inducement awards to 89 hires, issuing 258,200 options and 131,925 RSUs

Reuters
·
Apr 11

Vera Therapeutics announces annual shareholder meeting

Reuters
·
Apr 10